The Journal of Clinical Pharmacology · 1985 · 20 citations · 9 references
MedicineNephrologyUrologyMineral MetabolismRenal PharmacokineticsUrolithiasisMetabolic EvaluationRenal DiseaseRenal ExcretionRenal PharmacologyStone PathogenesisUrinary ExcretionSolubilityStone Formation PathophysiologyUrinary Metabolite ProfilingUrine Chemistries
As triamterene users may form kidney stones containing deposits of triamterene and its metabolites, we studied urinary excretion to detect any altered metabolism of triamterene in these patients. We found no significant differences between patients and matched control subjects in total recovery, hourly excretion patterns, and concentrations of triamterene and its sulfate metabolite. Approximately half of all subjects tested revealed urine concentrations of the sulfate metabolite that exceeded the observed solubility limit.
9
Bruce Ettinger · JAMA · 1980 · 80 citations
Triamterene-Induced Nephrolithiasis
Bruce Ettinger, Eli Weil, Neils. Mandel et al. · Annals of Internal Medicine · 1979 · 59 citations
Triamterene and Renal Stone Formation
Donald J. White, George H. Nancollas · The Journal of Urology · 1982 · 34 citations
Medicine, Nephrology, Urology +13